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Background: Intravascular stent (IS) placement for coarctation of aorta (COA) in children is controversial because of concerns regarding the safety 
of stent redilation due to somatic growth. We report acute and intermediate follow-up results from a prospective multicenter study.
Methods: Data was collected from Congenital Cardiovascular Interventional Study Consortium from 2000 to 2010. A Total of 144 children 
underwent IS placement from 30 centers for COA, median age 10 yrs (2-12) & weight 34 kg (6-95kg). Follow-up with integrated imaging (CT, MRI, 
cath) n= 84 patients (58%). Hypertension (HTN) was defined as >97.5%le for age.
Results: The COA diameter, COA/DAO ratio, mean systolic gradient significantly improved post IS from 5.93 (±2.58) to 11.63 (±2.71), 0.44 (±0.18) 
to 0.86 (±0.19) & 29.52 (±14.39) to3.69 (±5.64), respectively (p<0.0001). Repeat interventions were performed in 20 patients, 8 unplanned and 
15 had planned reintervention. There was significant improvement in COA diameter, COA / DAO ratio post reintervention compared to post initial 
stent placement Table 1. On follow-up, median duration 1.29 yrs, Aortic wall complications n=1 (aneurysm n=1), n= 12 had systolic HTN, n=21 were 
on HTN medications.
Conclusion: IS therapy for COA in children is feasible with excellent short term results. Follow-up and limited reintervention data may suggest 
favorable redilation potential following planned dilation with somatic growth.
Table 1. Baseline and reintervention data 
Characteristics
n=20
Initial stent placement Reintervention
Coarctation diameter in mm
Pre-stent
Post-stent
5.3(±2.9)
9.7(±3.0)
9.8(±4.2)
12.9(±3.68)
p-value=<0.0001
COA / DAO ratio
Pre-stent
Post-stent
0.38(±0.2)
0.70(±0.2)
0.64(±0.2)
0.83(±0.2)
(p-value=0.007)
COA gradient in mmHG
Pre-stent
Post-stent
34.7(±17.9)
9.65(±8.7)
24.8(±15.2)
7.6(±7.4)
